Association between functional polymorphisms in genes involved in the MAPK signaling pathways and cutaneous melanoma risk.

Journal Article (Journal Article)

Genome-wide association studies (GWASs) have mainly focused on top significant single nucleotide polymorphisms (SNPs), most of which did not have clear biological functions but were just surrogates for unknown causal variants. Studying SNPs with modest association and putative functions in biologically plausible pathways has become one complementary approach to GWASs. To unravel the key roles of mitogen-activated protein kinase (MAPK) pathways in cutaneous melanoma (CM) risk, we re-evaluated the associations between 47 818 SNPs in 280 MAPK genes and CM risk using our published GWAS dataset with 1804 CM cases and 1026 controls. We initially found 105 SNPs with P ≤ 0.001, more than expected by chance, 26 of which were predicted to be putatively functional SNPs. The risk associations with 16 SNPs around DUSP14 (rs1051849) and a previous reported melanoma locus MAFF/PLA2G6 (proxy SNP rs4608623) were replicated in the GenoMEL dataset (P < 0.01) but failed in the Australian dataset. Meta-analysis showed that rs1051849 in the 3' untranslated regions of DUSP14 was associated with a reduced risk of melanoma (odds ratio = 0.89, 95% confidence interval: 0.82-0.96, P = 0.003, false discovery rate = 0.056). Further genotype-phenotype correlation analysis using the 90 HapMap lymphoblastoid cell lines from Caucasians showed significant correlations between two SNPs (rs1051849 and rs4608623) and messenger RNA expression levels of DUSP14 and MAFF (P = 0.025 and P = 0.010, respectively). Gene-based tests also revealed significant SNPs were over-represented in MAFF, PLA2G6, DUSP14 and other 16 genes. Our results suggest that functional SNPs in MAPK pathways may contribute to CM risk. Further studies are warranted to validate our findings.

Full Text

Duke Authors

Cited Authors

  • Liu, H; Wang, L-E; Liu, Z; Chen, WV; Amos, CI; Lee, JE; Q-MEGA and AMFS Investigators, ; GenoMEL Investigators, ; Iles, MM; Law, MH; Barrett, JH; Montgomery, GW; Taylor, JC; MacGregor, S; Cust, AE; Newton Bishop, JA; Hayward, NK; Bishop, DT; Mann, GJ; Affleck, P; Wei, Q

Published Date

  • April 2013

Published In

Volume / Issue

  • 34 / 4

Start / End Page

  • 885 - 892

PubMed ID

  • 23291271

Pubmed Central ID

  • PMC3616673

Electronic International Standard Serial Number (EISSN)

  • 1460-2180

Digital Object Identifier (DOI)

  • 10.1093/carcin/bgs407


  • eng

Conference Location

  • England